Share Price and Basic Stock Data
Last Updated: July 26, 2025, 2:50 pm
| PEG Ratio | 0.00 |
|---|
Quick Insight
Hindustan Organic Chemicals Ltd (HOCL), operating in the organic chemicals sector, currently trades at ₹37.3 with a market capitalization of ₹251 crore. The company's return on equity (ROE) stands at a commendable 21.7%, indicating effective management of shareholder funds, while its return on capital employed (ROCE) of 5.22% suggests room for improvement in capital efficiency. However, key financial metrics such as net profit, operating profit margin, and borrowings remain undisclosed, raising concerns about transparency. Investors should approach HOCL cautiously, focusing on the company's ability to enhance operational metrics and disclose comprehensive financial data to build trust and attract institutional investment.
Competitors of Hindustan Organic Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 245 Cr. | 36.5 | 62.7/22.4 | 156 | 0.00 % | 5.22 % | 21.7 % | 10.0 | |
| Vinati Organics Ltd | 19,373 Cr. | 1,869 | 2,331/1,412 | 46.7 | 271 | 0.37 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 51.9 Cr. | 19.5 | 38.8/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 9,809.00 Cr | 641.67 | 46.70 | 245.33 | 0.12% | 8.78% | 12.76% | 7.00 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 196 | 124 | 139 | 174 | 194 | 145 | 189 | 187 | 183 | 59 | 175 | 165 | 137 |
| Expenses | 172 | 125 | 157 | 173 | 177 | 154 | 177 | 190 | 183 | 83 | 175 | 191 | 173 |
| Operating Profit | 25 | -1 | -17 | 1 | 16 | -9 | 11 | -3 | -1 | -24 | 0 | -26 | -37 |
| OPM % | 13% | -1% | -12% | 1% | 8% | -6% | 6% | -2% | -0% | -40% | 0% | -16% | -27% |
| Other Income | 26 | 2 | 9 | 3 | -5 | 3 | 5 | 4 | 7 | 5 | 5 | -35 | 551 |
| Interest | 18 | 16 | 13 | 17 | 17 | 17 | 17 | 18 | 17 | 16 | 18 | 18 | -10 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 32 | -15 | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 523 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
| Net Profit | 32 | -15 | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 520 |
| EPS in Rs | 5.04 | -2.15 | -3.12 | -2.01 | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 |
Last Updated: May 31, 2025, 5:42 am
Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 165.00 Cr. (Dec 2024) to 137.00 Cr., marking a decrease of 28.00 Cr..
- For Expenses, as of Mar 2025, the value is 173.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 191.00 Cr. (Dec 2024) to 173.00 Cr., marking a decrease of 18.00 Cr..
- For Operating Profit, as of Mar 2025, the value is -37.00 Cr.. The value appears to be declining and may need further review. It has decreased from -26.00 Cr. (Dec 2024) to -37.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Mar 2025, the value is -27.00%. The value appears to be declining and may need further review. It has decreased from -16.00% (Dec 2024) to -27.00%, marking a decrease of 11.00%.
- For Other Income, as of Mar 2025, the value is 551.00 Cr.. The value appears strong and on an upward trend. It has increased from -35.00 Cr. (Dec 2024) to 551.00 Cr., marking an increase of 586.00 Cr..
- For Interest, as of Mar 2025, the value is -10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.00 Cr. (Dec 2024) to -10.00 Cr., marking a decrease of 28.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 523.00 Cr.. The value appears strong and on an upward trend. It has increased from -79.00 Cr. (Dec 2024) to 523.00 Cr., marking an increase of 602.00 Cr..
- For Tax %, as of Mar 2025, the value is 1.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2024) to 1.00%, marking an increase of 1.00%.
- For Net Profit, as of Mar 2025, the value is 520.00 Cr.. The value appears strong and on an upward trend. It has increased from -79.00 Cr. (Dec 2024) to 520.00 Cr., marking an increase of 599.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 77.39. The value appears strong and on an upward trend. It has increased from -11.76 (Dec 2024) to 77.39, marking an increase of 89.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 19, 2025, 11:52 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 |
| Expenses | 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% |
| Other Income | 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% |
| Net Profit | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.43% | 14.75% | -40.00% | 27.80% | 139.04% | -234.25% | 91.84% | -300.00% | -71.88% | 1.82% | 825.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.17% | -54.75% | 67.80% | 111.24% | -373.28% | 326.08% | -391.84% | 228.12% | 73.69% | 824.11% |
Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 7% |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -2% |
| 3 Years: | % |
| TTM: | -95% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 23% |
| 3 Years: | 7% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -22% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 1:06 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 |
| Borrowings | 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 206 |
| Other Liabilities | 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 313 |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,564 |
| Fixed Assets | 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,333 |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,564 |
Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 67.00 Cr..
- For Reserves, as of Mar 2025, the value is 978.00 Cr.. The value appears strong and on an upward trend. It has increased from -119.00 Cr. (Mar 2024) to 978.00 Cr., marking an increase of 1,097.00 Cr..
- For Borrowings, as of Mar 2025, the value is 206.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,362.00 Cr. (Mar 2024) to 206.00 Cr., marking a decrease of 1,156.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 313.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 264.00 Cr. (Mar 2024) to 313.00 Cr., marking an increase of 49.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,564.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,575.00 Cr. (Mar 2024) to 1,564.00 Cr., marking a decrease of 11.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 227.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2024) to 227.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,349.00 Cr. (Mar 2024) to 1,333.00 Cr., marking a decrease of 16.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,564.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2024) to 1,564.00 Cr., marking a decrease of 11.00 Cr..
Notably, the Reserves (978.00 Cr.) exceed the Borrowings (206.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -702.00 | -827.00 | -824.00 | -762.00 | -776.00 | -578.00 | -579.00 | -491.00 | 0.00 | 5.00 | -2.00 | -292.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 49 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 21 |
| Working Capital Days | -414 | -626 | -1,197 | -2,076 | 691 | 434 | 387 | 307 | 551 | 311 | 232 | 619 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Diluted EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Cash EPS (Rs.) | 58.51 | -7.83 | -8.05 | -4.19 | -0.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Revenue From Operations / Share (Rs.) | 79.66 | 104.64 | 93.87 | 64.47 | 61.70 |
| PBDIT / Share (Rs.) | -9.42 | 2.33 | 1.90 | 3.45 | 7.10 |
| PBIT / Share (Rs.) | -9.67 | 2.12 | 1.72 | 3.28 | 6.67 |
| PBT / Share (Rs.) | 58.70 | -8.22 | -8.23 | -4.37 | -1.30 |
| Net Profit / Share (Rs.) | 58.27 | -8.04 | -8.23 | -4.37 | -1.30 |
| NP After MI And SOA / Share (Rs.) | 58.24 | -8.12 | -7.89 | -3.97 | -1.61 |
| PBDIT Margin (%) | -11.82 | 2.22 | 2.02 | 5.35 | 11.50 |
| PBIT Margin (%) | -12.13 | 2.02 | 1.83 | 5.08 | 10.80 |
| PBT Margin (%) | 73.68 | -7.85 | -8.76 | -6.77 | -2.11 |
| Net Profit Margin (%) | 73.14 | -7.68 | -8.76 | -6.77 | -2.11 |
| NP After MI And SOA Margin (%) | 73.11 | -7.76 | -8.41 | -6.15 | -2.60 |
| Return on Networth / Equity (%) | 37.47 | 0.00 | 0.00 | 0.00 | -34.97 |
| Return on Capital Employeed (%) | -5.43 | 14.22 | 11.03 | 13.99 | 16.73 |
| Return On Assets (%) | 25.04 | -3.47 | -3.56 | -1.81 | -0.75 |
| Long Term Debt / Equity (X) | 0.00 | -0.04 | 0.00 | 0.00 | 2.49 |
| Total Debt / Equity (X) | 0.19 | -16.20 | -16.51 | -197.52 | 13.60 |
| Asset Turnover Ratio (%) | 0.34 | 0.45 | 0.42 | 0.29 | 0.29 |
| Current Ratio (X) | 3.61 | 0.91 | 0.95 | 0.99 | 1.11 |
| Quick Ratio (X) | 3.46 | 0.86 | 0.91 | 0.94 | 1.06 |
| Inventory Turnover Ratio (X) | 6.84 | 8.48 | 6.77 | 4.34 | 3.97 |
| Interest Coverage Ratio (X) | -1.48 | 0.22 | 0.19 | 0.45 | 0.89 |
| Interest Coverage Ratio (Post Tax) (X) | -1.59 | 0.20 | 0.17 | 0.42 | 0.83 |
| Enterprise Value (Cr.) | 201.55 | 807.36 | 730.02 | 377.91 | 507.33 |
| EV / Net Operating Revenue (X) | 0.37 | 1.15 | 1.16 | 0.87 | 1.22 |
| EV / EBITDA (X) | -3.18 | 51.44 | 57.21 | 16.27 | 10.63 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| Price / BV (X) | 0.27 | -5.13 | -3.05 | -102.76 | 8.62 |
| Price / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| EarningsYield | 1.37 | -0.20 | -0.35 | -0.14 | -0.04 |
After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
- For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
- For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
- For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
- For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
- For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
- For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.48 (Mar 24) to 6.84, marking a decrease of 1.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
- Net Profit Margin: 73.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.43% (Industry Average ROCE: 8.78%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.47% (Industry Average ROE: 12.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 46.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 73.14%
About the Company - Qualitative Analysis
Hindustan Organic Chemicals Ltd. is a Public Limited Listed company incorporated on 12/12/1960 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L99999KL1960GOI082753 and registration number is 082753. Currently company belongs to the Industry of Chemicals - Organic - Benzene Based. Company's Total Operating Revenue is Rs. 535.87 Cr. and Equity Capital is Rs. 67.27 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | Ambalamugal PO, Kunnathnad, Ernakulam Kerala 682302 | cs@hoclindia.com www.hoclindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. B Sanjeev | Chairman & Managing Director |
| Mr. Yogendra Prasad Shukla | Director - Finance |
| Mr. Kanishk Kant Srivastava | Government Nominee Director |
| Dr. Bharat J Kanabar | Non Official Independent Director |
| Mr. Pratyush Mandal | Non Official Independent Director |
| Mr. Manoj Sethi | Government Nominee Director |
FAQ
What is the intrinsic value of Hindustan Organic Chemicals Ltd?
Hindustan Organic Chemicals Ltd's intrinsic value (as of 26 July 2025) is 414.35 1035.21% higher the current market price of 36.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 245 Cr. market cap, FY2025-2026 high/low of 62.7/22.4, reserves of 978 Cr, and liabilities of 1,564 Cr.
What is the Market Cap of Hindustan Organic Chemicals Ltd?
The Market Cap of Hindustan Organic Chemicals Ltd is 245 Cr..
What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 26 July 2025?
The current stock price of Hindustan Organic Chemicals Ltd as on 26 July 2025 is 36.5.
What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Organic Chemicals Ltd stocks is ₹62.7/22.4.
What is the Stock P/E of Hindustan Organic Chemicals Ltd?
The Stock P/E of Hindustan Organic Chemicals Ltd is .
What is the Book Value of Hindustan Organic Chemicals Ltd?
The Book Value of Hindustan Organic Chemicals Ltd is 156.
What is the Dividend Yield of Hindustan Organic Chemicals Ltd?
The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.
What is the ROCE of Hindustan Organic Chemicals Ltd?
The ROCE of Hindustan Organic Chemicals Ltd is 5.22 %.
What is the ROE of Hindustan Organic Chemicals Ltd?
The ROE of Hindustan Organic Chemicals Ltd is 21.7 %.
What is the Face Value of Hindustan Organic Chemicals Ltd?
The Face Value of Hindustan Organic Chemicals Ltd is 10.0.